Evidence map›Paper›PMID 41595552›Full record

ArticleBiomedicines2025

Pharmacologic Inhibition of S-Nitrosoglutathione Reductase Prevents Hyperoxic Alveolar and Airway Disease in Newborn Mice.

Stephanie Adaikalam, Ramadan B Sopi, Laura A Smith, Anjum Jafri, Peter M MacFarlane, Richard J Martin, Benjamin Gaston, Thomas M Raffay

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stephanie AdaikalamDivision of Pediatric Pulmonology, Allergy, and Sleep Medicine, Department of Pediatrics, Indiana University, Indianapolis, IN 46202, USA.ORCID 0000-0002-5063-7574
Ramadan B SopiSchool of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Laura A SmithDivision of Pediatric Pulmonology, Allergy, and Sleep Medicine, Department of Pediatrics, Indiana University, Indianapolis, IN 46202, USA.ORCID 0000-0002-4694-0482
Anjum JafriSchool of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Peter M MacFarlaneSchool of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-5373-7095
Richard J MartinSchool of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Benjamin GastonDivision of Pediatric Pulmonology, Allergy, and Sleep Medicine, Department of Pediatrics, Indiana University, Indianapolis, IN 46202, USA.
Thomas M RaffaySchool of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-6572-8719

Funding

S-nitrosylation signaling in asthmaP01HL158507 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI LAHM, TIM · 2021 to 2025
$12.0M
S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lungR01HL172894 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI Thomas Michael Raffay · 2024 to 2026
$1.7M
NHLBI NIH HHS P01 HL158507NHLBI NIH HHS R01 HL172894NIH HHS 5P01HL158507-05NIH HHS 5R01HL172894-02
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

airway hyperreactivitybronchopulmonary dysplasiaoxygenS-nitrosothiol

Identifiers

PMID41595552
PMCPMC12837470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.